Explore how Epstein-Barr virus, carried by 95% of adults, can manipulate cellular mechanisms to cause cancer and the latest research breakthroughs.
Explore groundbreaking therapies targeting Epstein-Barr virus-infected cells, including immunotherapy, small molecule inhibitors, and the latest research discoveries.
Exploring the prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in transplant recipients through cutting-edge medical strategies.